PAVmed Inc.
PAVM
$0.71
$0.034.41%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 10.00K | 996.00K | 979.00K | 1.01M | 1.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.00K | 996.00K | 979.00K | 1.01M | 1.05M |
| Cost of Revenue | 48.00K | 1.38M | 1.67M | 1.74M | 1.61M |
| Gross Profit | -38.00K | -385.00K | -687.00K | -734.00K | -562.00K |
| SG&A Expenses | 4.34M | 9.57M | 11.25M | 10.99M | 11.72M |
| Depreciation & Amortization | 0.00 | 82.00K | 105.00K | 372.00K | 505.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.20M | 12.57M | 14.66M | 15.05M | 17.43M |
| Operating Income | -5.19M | -11.58M | -13.68M | -14.04M | -16.38M |
| Income Before Tax | 1.14M | 60.71M | -14.91M | -18.51M | -17.41M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1.14M | 60.71M | -14.91M | -18.51M | -17.41M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 289.00K | 3.69M | 4.09M | 3.30M | 3.37M |
| Net Income | 1.43M | 64.40M | -10.83M | -15.21M | -14.04M |
| EBIT | -5.19M | -11.58M | -13.68M | -14.04M | -16.38M |
| EBITDA | -5.12M | -11.34M | -13.38M | -13.45M | -15.66M |
| EPS Basic | 0.12 | 6.43 | -1.19 | -2.62 | -1.98 |
| Normalized Basic EPS | -0.06 | -0.31 | -0.48 | -0.63 | -1.33 |
| EPS Diluted | -0.01 | 1.44 | -1.19 | -2.62 | -1.98 |
| Normalized Diluted EPS | 0.00 | -0.07 | -0.48 | -0.63 | -1.33 |
| Average Basic Shares Outstanding | 10.83M | 10.01M | 9.15M | 8.69M | 8.02M |
| Average Diluted Shares Outstanding | 131.96M | 44.48M | 9.15M | 8.69M | 8.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |